Approaches for Early Diagnosis, Risk Stratification, and Multidisciplinary Management of Stage I/II Melanoma

Approaches for Early Diagnosis, Risk Stratification, and Multidisciplinary Management of Stage I/II Melanoma is organized by Prime Education, LLC.

Release Date: February 14, 2020
Expire Date: February 14, 2021

Accreditation: 
Physician Credit Designation Statement:
PRIME® designates this Enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Interprofessional Teams
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credits for learning and change.

Nurse Practitioner Accreditation Statement:
This activity is approved for 1.0 contact hour of continuing education (which includes 0.1 hour of pharmacology) by the American Association of Nurse Practitioners.

Physician Assistant Accreditation Statement:
PRIME® has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation. 

Pharmacist Accreditation Statement:
This Application-based activity has been approved for 1.0 contact hour (0.1 CEUs) by PRIME® for pharmacists. 

Nurse Accreditation Statement:
PRIME® designates this activity for 1.0 contact hour.

Case Manager Accreditation Statement:
The Commission for Case Manager Certification designates this educational activity for 1.0 contact hour for certified case managers.

Overview:
Identifying and treating early stage melanoma is associated with higher survival rates, but diagnosis at early stages remains a clinical challenge. Improving survival for melanoma is also difficult, due to its aggressiveness, metastatic potential, and lack of routine screening. Therefore, improving early diagnosis, risk stratification, and multidisciplinary care of early stage melanoma is critical to improve patient survival and ensure appropriate treatment interventions for patients with stage I/II melanoma.

Listen as leading melanoma experts discuss evidence-based strategies for integrating the best guideline-compliant therapies and novel treatment approaches for early stage melanoma. Evaluate methodologies for using patient-centered approaches for screening, diagnosis, treatment decision-making, and care coordination.